ATE306259T1 - Stabile pharmazeutische zubereitung auf basis von acetylsalicylsäure und tocopherol - Google Patents

Stabile pharmazeutische zubereitung auf basis von acetylsalicylsäure und tocopherol

Info

Publication number
ATE306259T1
ATE306259T1 AT96402398T AT96402398T ATE306259T1 AT E306259 T1 ATE306259 T1 AT E306259T1 AT 96402398 T AT96402398 T AT 96402398T AT 96402398 T AT96402398 T AT 96402398T AT E306259 T1 ATE306259 T1 AT E306259T1
Authority
AT
Austria
Prior art keywords
tocopherol
salicylic acid
pharmaceutical preparation
stable pharmaceutical
preparation based
Prior art date
Application number
AT96402398T
Other languages
English (en)
Inventor
Cyril Estanove
Alain Prudhomme
Original Assignee
Mazal Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mazal Pharma filed Critical Mazal Pharma
Application granted granted Critical
Publication of ATE306259T1 publication Critical patent/ATE306259T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT96402398T 1995-11-23 1996-11-12 Stabile pharmazeutische zubereitung auf basis von acetylsalicylsäure und tocopherol ATE306259T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9513933A FR2741534B1 (fr) 1995-11-23 1995-11-23 Composition pharmaceutique stable a base d'acide acetylsalicylique et de tocopherol

Publications (1)

Publication Number Publication Date
ATE306259T1 true ATE306259T1 (de) 2005-10-15

Family

ID=9484850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96402398T ATE306259T1 (de) 1995-11-23 1996-11-12 Stabile pharmazeutische zubereitung auf basis von acetylsalicylsäure und tocopherol

Country Status (9)

Country Link
EP (1) EP0775488B1 (de)
JP (1) JPH09263538A (de)
AT (1) ATE306259T1 (de)
CA (1) CA2190807C (de)
DE (1) DE69635262T2 (de)
DK (1) DK0775488T3 (de)
ES (1) ES2249777T3 (de)
FR (1) FR2741534B1 (de)
SI (1) SI0775488T1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462601B2 (en) 2002-03-26 2008-12-09 Tsutomu Kagiya Ameliorant for chemical treatment of cancer
JP2008534591A (ja) * 2005-03-29 2008-08-28 マクニール−ピーピーシー・インコーポレーテツド 疎水性溶媒内に親水性薬剤を有する組成物
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2486541A (en) 1946-07-19 1949-11-01 Distillation Products Inc Delta-tocopherol
US2890240A (en) 1956-03-28 1959-06-09 Monsanto Chemicals Aspirin crystallisation
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
US3235583A (en) 1964-07-22 1966-02-15 Norwich Pharma Co Preparation of aspirin
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
JPS5438164B2 (de) * 1972-05-29 1979-11-19
US4454112A (en) 1977-12-27 1984-06-12 Henkel Corporation Sunscreen composition containing tocopherol acetylsalicylate
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
EP0204987B1 (de) * 1985-05-15 1991-11-21 Roshdy Dr. Ismail Vitamin E-haltiges Mittel zur Verbesserung der Eigenschaften des Blutes
EP0669132A1 (de) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Kombinationspräparat von Vitamine E und Acetylsalicylate zur Behandlung und Prophylaxis des Atherosclerosis

Also Published As

Publication number Publication date
DE69635262T2 (de) 2006-07-13
DK0775488T3 (da) 2006-02-13
CA2190807C (fr) 2007-07-10
EP0775488A1 (de) 1997-05-28
SI0775488T1 (sl) 2006-02-28
FR2741534A1 (fr) 1997-05-30
ES2249777T3 (es) 2006-04-01
FR2741534B1 (fr) 1998-09-11
EP0775488B1 (de) 2005-10-12
CA2190807A1 (fr) 1997-05-24
DE69635262D1 (de) 2006-02-23
JPH09263538A (ja) 1997-10-07

Similar Documents

Publication Publication Date Title
CA2162993A1 (en) Solid fat nanoemulsions as drug delivery vehicles
IL90435A0 (en) 4-(quinolin-2-yl-methoxy)phenylacetic acid derivatives,their preparation and pharmaceutical compositions containing them
FI971880A0 (fi) Helposti sulavan kantajan sisältävä farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
GR3020843T3 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
ATE310519T1 (de) Arzneizusammensetzungen enthaltend ascomyzinderivate
HUP0103886A2 (hu) Azonnali hatóanyag-kibocsátású, peptidalapú trombininhibitort tartalmazó tabletta, eljárás előállítására és alkalmazása
WO1997003655A1 (en) Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
NZ212268A (en) Sustained release composition containing pyridyl-pyridinone derivatives and preparation thereof
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
FR2726469B1 (fr) Composition pharmaceutique pour l'administration orale de flavonoides
AU4846690A (en) Polyunsaturated fatty acid derivatives, pharmaceutical compositions containing the same, method for the preparation thereof, and their use as medicament
EE9900140A (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
ATE306259T1 (de) Stabile pharmazeutische zubereitung auf basis von acetylsalicylsäure und tocopherol
IL90613A0 (en) Chroman derivatives and pharmaceutical compositions containing them
IL89542A0 (en) Pyrimidinyl-substituted hydroxyacids,lactones and esters,their preparation and pharmaceutical compositions containing them
WO2003018064A3 (en) Lipophilic drug compositions
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
DE59409275D1 (de) Tabletten mit Thioctsäure bestimmter Korngrösse
ATE93136T1 (de) Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.
DE69428455D1 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
ZA898782B (en) Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimodo(6,1-a)isoquinolin-4-one derivatives and their use
KR960006913A (ko) 변성이 방지된 경질 젤라틴 캡슐 및 그의 제조 방법
KR930021206A (ko) 시타라빈 옥포스페이트 경질 캡슐제
ATE267585T1 (de) Micronisierte pharmazeutische zusammensetzungen
KR920703501A (ko) 세바스산 및 그 유도체의 장 경우 영양 및 비경구적 영양에서의 용도 및 이들 화합물을 함유한 의약 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0775488

Country of ref document: EP

REN Ceased due to non-payment of the annual fee